ACEA Biosciences Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 201

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $250M

ACEA Biosciences General Information

Description

Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. The company's instruments use microelectrodes in automated high-throughput plate formats to offer real time cell analysis, enabling doctors to monitor cell proliferation, cell size, cell-substrate attachment quality and cell invasion easily.

Contact Information

Website
www.aceabio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6779 Mesa Ridge Road
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • 6779 Mesa Ridge Road
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACEA Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 14-Nov-2018 $250M Completed Generating Revenue
6. Later Stage VC (Series E) 01-Apr-2016 Completed Generating Revenue
5. Grant 03-Jul-2013 Completed Generating Revenue
4. Later Stage VC (Series D) 10-Sep-2007 Completed Generating Revenue
3. Later Stage VC (Series C) Completed Generating Revenue
2. Early Stage VC (Series B) $1.85M $4.15M Completed Generating Revenue
1. Early Stage VC (Series A) $2.3M $2.3M Completed Generating Revenue
To view ACEA Biosciences’s complete valuation and funding history, request access »

ACEA Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 1,589,690 $0.001000 4% $1.16 $1.16 1x $1.16 7.98%
Series A 3,199,414 $0.001000 4% $0.95 $0.95 1x $0.95 16.06%
To view ACEA Biosciences’s complete cap table history, request access »

ACEA Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. The company's
Other Devices and Supplies
San Diego, CA
201 As of 2016

San Diego, CA
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACEA Biosciences Competitors (22)

One of ACEA Biosciences’s 22 competitors is Illumina, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Illumina Formerly VC-backed San Diego, CA
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom
Active Motif Private Equity-Backed Carlsbad, CA
Aviva Systems Biology Formerly VC-backed San Diego, CA
Cytena Formerly VC-backed Freiburg, Germany
You’re viewing 5 of 22 competitors. Get the full list »

ACEA Biosciences Patents

ACEA Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019527839-A Optical detection system for flow cytometer, flow cytometer system and method of use Active 15-Jul-2016
EP-3071951-A4 Optical engine for flow cytometer, flow cytometer system and methods of use Active 19-Nov-2013
EP-3071951-B1 Optical engine for flow cytometer, flow cytometer system and methods of use Active 19-Nov-2013
EP-3071951-A2 Optical engine for flow cytometer, flow cytometer system and methods of use Active 19-Nov-2013
CA-2917364-C Heterocyclic compounds and uses thereof Active 11-Jul-2013 C07D417/12
To view ACEA Biosciences’s complete patent history, request access »

ACEA Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ACEA Biosciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lilly Asia Ventures Corporate Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
U.S. Environmental Protection Agency Government
To view ACEA Biosciences’s complete investors history, request access »

ACEA Biosciences FAQs

  • When was ACEA Biosciences founded?

    ACEA Biosciences was founded in 2002.

  • Where is ACEA Biosciences headquartered?

    ACEA Biosciences is headquartered in San Diego, CA.

  • What is the size of ACEA Biosciences?

    ACEA Biosciences has 201 total employees.

  • What industry is ACEA Biosciences in?

    ACEA Biosciences’s primary industry is Other Devices and Supplies.

  • Is ACEA Biosciences a private or public company?

    ACEA Biosciences is a Private company.

  • What is the current valuation of ACEA Biosciences?

    The current valuation of ACEA Biosciences is .

  • What is ACEA Biosciences’s current revenue?

    The current revenue for ACEA Biosciences is .

  • How much funding has ACEA Biosciences raised over time?

    ACEA Biosciences has raised $42.8M.

  • Who are ACEA Biosciences’s investors?

    Lilly Asia Ventures, Qiming Venture Partners, and U.S. Environmental Protection Agency have invested in ACEA Biosciences.

  • Who are ACEA Biosciences’s competitors?

    Illumina, Sphere Fluidics, Active Motif, Aviva Systems Biology, and Cytena are some of the 22 competitors of ACEA Biosciences.

  • When was ACEA Biosciences acquired?

    ACEA Biosciences was acquired on 14-Nov-2018.

  • Who acquired ACEA Biosciences?

    ACEA Biosciences was acquired by Agilent Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »